Diagnosis of precancerous lesions of the breast

Authors

  • D. I. Kebalo CRDC COMREC, Zaporizhzhia, Ukraine,
  • N. P. Miroshnykova CRDC COMREC, Zaporizhzhia, Ukraine,
  • O. P. Shershniova CRDC COMREC, Zaporizhzhia, Ukraine,
  • S. M. Pashchenko SI “Zaporizhzhia Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine”,
  • E. D. Zvantseva Zaporizhzhia Regional Clinical Oncology Hospital, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2020.3.204917

Keywords:

mammary gland, biochemical tumor markers, immunocytochemistry

Abstract

 

The purpose of this work is to determine the optimal markers for clarifying the degree of proliferative activity in benign breast lesions, which can be used in surgical treatment planning.

Materials and methods. The immunocytochemical results of tumor proliferation marker (Ki-67), cancer-embryonic antigen (CEA), matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) expression were studied in biopsy samples collected from 108 patients with benign breast lesions and 49 patients with breast cancer.

Results. It was found that the proliferative processes rising was accompanied by an increase in the number of patients with expression of Ki-67 to 28.0 %, CEA to 44.0 %, VEGF to 80.0 %, and a decrease in the number of patients with MMP-9 expression from 75.0 % to 36.4 %. Among patients with breast cancer, cells expressing Ki-67 were observed in 36.8 %, MMP-9 in 20.7 %, CEA in 36.4 %, VEGF in 48.3 %. The results indicate the presence of a neoplastic potential in benign lesions and its enhancement with an increase in proliferative properties.

Conclusions. This diagnostic method can be used to determine the malignant potential in benign breast lesions and for therapeutic decision making.

 

References

Kushnarev, V. A., Artemyeva, E. S., & Kudaybergenova, A. G. (2018). Sravnenie tsifrovogo i vizual'nogo metodov otsenki Ki-67 v invazivnykh kartsinomakh molochnoi zhelezy [Comparison of digital and visual methods for Ki-67 assessment in invasive breast carcinomas]. Arkhiv patologii, 80(2), 38-42. https://doi.org/10.17116/patol201880238-42 [in Russian].

Markelova, E. V., Zdor, V. V., Romanchuk, A. L., & Birko, O. N. (2016). Matriksnye metalloproteinazy: ikh vzaimosvyaz' s sistemoi tsitokinov, diagnosticheskii i prognosticheskii potentsial [Matrix metalloproteinases: on their relationship with cytokine system, diagnostic and prognostic potential]. Immunologiya, allergologiya, infektologiya, (2), 11-22. https://doi.org/10.14427/jipai.2016.2.23 [in Russian].

Nefedova, N. A., Kharlova, O. A., Danilova, N. V., Malkov, P. G., & Gaifullin, N. M. (2016). Markery angiogeneza pri opukholevom roste [Markers of angiogenesis in tumor growth]. Arkhiv patologii, 78(2), 55-62. https://doi.org/10.17116/patol201678255-62 [in Russian].

Savostikova, M. V., Korotkikh, I. Yu., & Laktionov, K. P. (2014). Immunotsitokhimicheskoe opredelenie vazhneishikh faktorov prognoza u bol'nykh rakom molochnoi zhelezy [Immunocytochemical determination of the most important prognostic factors in patients with breast cancer]. Onkologiya. Zhurnal im. P. A. Gertsena, 2(1), 33-36. [in Russian].

Volchenko, N. N., & Slavnova, E. N. (Eds). (2014). Sovremennaya tsitologicheskaya diagnostika zabolevanii molochnoi zhelezy [Modern cytological diagnosis of breast diseases]. Izd-vo MGTU im. N. E. Baumana. [in Russian].

Fedorenko, Z. P., Michailovich, Y. I., Gulak, L. O., Gorokh, Y. L., Ryzhov, A. Y., Sumkina, O. V., & Kutsenko, L. B. (2018). Epidemiolohichni ta orhanizatsiini peredumovy vprovadzhennia skryninhu raku hrudnoi zalozy v Ukraini [Epidemiological and organisational background of breast cancer screening in Ukraine]. Klynycheskaia onkolohyia, 8(3), 1-7. [in Ukrainian].

Gnant, M., Thomssen, C., & Harbeck, N. (2015). St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion. Breast Care (Basel, Switzerland), 10(2), 124-130. https://doi.org/10.1159/000430488

Penault-Llorca, F., & Radosevic-Robin, N. (2017). Ki67 assessment in breast cancer: an update. Pathology, 49(2), 166-171. https://doi.org/10.1016/j.pathol.2016.11.006

Petrelli, F., Viale, G., Cabiddu, M., & Barni, S. (2015). Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients. Breast Cancer Research and Treatment, 153(3), 477-491. https://doi.org/10.1007/s10549-015-3559-0

Downloads

How to Cite

1.
Kebalo DI, Miroshnykova NP, Shershniova OP, Pashchenko SM, Zvantseva ED. Diagnosis of precancerous lesions of the breast. Zaporozhye Medical Journal [Internet]. 2020Jun.10 [cited 2024Dec.23];22(3). Available from: http://zmj.zsmu.edu.ua/article/view/204917

Issue

Vol. 22 No. 3 (2020)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)